6 Nipple Facts Doctors Actually Want You to Know
SELF Magazine – Aug. 10
“This is no different than the various shapes of eyes or colors of eyes from person to person,” Susan Hoover, M.D., F.A.C.S., a surgical oncologist in the Breast Oncology Program at Moffitt Cancer Center in Tampa, Florida, tells SELF.
Exciting Advances Are Coming for First-line CML Treatment
Cure Magazine – Aug. 10
The common practice has been to keep a patient on TKI therapy indefinitely, but according to Sweet, an assistant member in the Department of Malignant Hematology at Moffitt Cancer Center, TKI discontinuation has been achieved and continues to be studied. In order to increase the potential for treatment discontinuation, a new combination therapy approach might need to be taken — something that Sweet says is currently being explored.
Treating CINV Due to Immunotherapy and Targeted Therapy
OncLive – Aug. 9
Dawn Dolan, PharmD, BCOP: Nausea with immunotherapy, though, can be very complicated, too, because it could be an early sign of an endocrinopathy. It would be really tough to potentially differentiate whether it was pure nausea, from a nausea standpoint, or an early sign of a side effect.
Moffitt Cancer Center and Cvergenx form research partnership to revolutionize radiation therapy
News Medical – Aug. 9
Moffitt Cancer Center and Cvergenx announced a new research partnership that aims to revolutionize radiation therapy.
Improving Diagnostic Measures and Treatment for MPNs
Cure Magazine – Aug. 9
In an interview with CURE, Komrokji, vice chair of malignant hematology and section head for leukemia and MDS at Moffitt Cancer Center, shared his insight on the various types of MPNs, how these diseases can be diagnosed and managed, and the next steps needed to improve patient outcomes.
ORIEN cancer consortium taps HudsonAlpha for clinical trial sequencing support
Fierce Biotech – Aug. 9
M2Gen, an informatics research subsidiary of Moffitt Cancer Center, formed the Oncology Research Information Exchange Network (ORIEN) Avatar research program earlier this year to give drugmakers a way to access data analytics that support therapeutic development efforts. Celgene signed up as a founding industry member, with Takeda coming on board as a collaborator two months later. ORIEN is also working to ensure patients have access to relevant clinical trials.
Dr. Shain on Subcutaneous Therapy for Patients With Multiple Myeloma
OncLive – Aug. 8
Kenneth H. Shain, MD, PhD, assistant member, Moffitt Cancer Center, discusses the impact of subcutaneous therapy, such as bortezomib (Velcade) and daratumumab (Darzalex) for patients with multiple myeloma.
Meta-analysis offers key insights into testicular cancer’s ‘underlying genetic architecture’
Healio – Aug. 8
“Our findings substantially increase the number of known susceptibility genes associated with testicular germ cell tumors,” Peter Kanetsky, PhD, MPH, chair of the cancer epidemiology department at Moffitt Cancer Center, said in a press release.
The University of Texas MD Anderson Cancer Center named best cancer hospital in nation
Healio – Aug. 8
The top 10 cancer hospitals in this year’s rankings are: The University of Texas MD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center, Mayo Clinic in Rochester, Minnesota; Dana-Farber/Brigham and Women’s Cancer Center; Seattle Cancer Care Alliance/University of Washington Medical Center; Johns Hopkins Hospital; Cleveland Clinic; Hospitals of the University of Pennsylvania — Penn Presbyterian; H. Lee Moffitt Cancer Center and Research Institute; and UCSF Medical Center.
Breast Cancer Implants
KLAS-TV – Aug. 8
Moffitt Cancer Center oncologist Frederick Locke says recent FDA warnings show there have been 359 breast implant-associated lymphoma cases reported. Also seen on KXAS.
Pale is the new tan, Bradenton dermatologist tells patients
Bradenton Herald – Aug. 7
Tourists and residents in Florida can avoid the possible fatal outcomes from skin cancer with a game plan, said Dr. Nikhil Khushalani, one of the top cancer doctors at Tampa’s Moffitt Cancer Center, which is the National Cancer Institute’s only designated Comprehensive Cancer Center in Florida.
Choosing Your Own Training Adventure: Where Do You Start?
ASH Clinical News – Aug. 7
ASH Clinical News spoke with Leidy Isenalumhe, MD, MS,chair of the Trainee Council for 2017-2018, about the wonderful – but overwhelming – array of careers open to trainees, and the difficulties of transitioning from trainee to attending. Dr. Isenalumhe is a clinical hematology/oncology fellow at H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida.
Children of the Sun Safety Means "Slip, Slap, Slop"
Men’s Health-Top – Aug. 7
"Healthy sun-protection habits come in three forms-sometimes referred to as slip, slap, slop," said Dr. Vernon Sondak. He is Head of the Department of Skin Cancer at Moffitt Cancer Center in Tampa, Fla.
New Research Shows the Power of Radiomics to Improve Precision Medicine
LabManager – Aug. 7
Despite the progress that has been made in targeted cancer therapies, the path has been slow and scientists have a long road ahead. In a collaborative project, researchers at the Moffitt Cancer Center and Dana-Farber Cancer Institute investigated the emerging field of radiomics which has the potential to improve precision medicine by non-invasively assessing the molecular and clinical characteristics of lung tumors. Also seen on eCancer News.
Meet Lucy, A Moffitt Pet Therapy Dog
WTVT – Aug. 5
FDA Approves Combination for Therapy-Related Acute Myeloid Leukemia
Cancer Network – Aug. 4
“Vyxeos is the first chemotherapy to demonstrate an overall survival advantage over the standard of care in a phase III randomized study of older adults with newly-diagnosed therapy-related AML or AML with myelodysplasia-related changes,” said Jeffrey E. Lancet, MD, of the Department of Malignant Hematology at Moffitt Cancer Center, in a press release from Jazz Pharmaceuticals.
‘His saving Gracie’: Chipley teen gives father life-saving bone marrow donation
Washington County News – Aug. 4
For years, Nick was able to keep the cancer at bay through oral chemotherapy while in the chronic phase, but following three relapses, the family learned in April that Nick was in the blast crisis phase. He was immediately sent to Moffitt Cancer Center in Tampa, where he was told he needed a bone marrow transplant to fight the cancer’s renewed aggression.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.